UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000059539
Receipt number R000067917
Scientific Title Improvement Effects of Intake of Resveratrol-containing Extracts from Pterocarpus marsupiumand and Red Wine Combined with Palmitoyl Vitamin C on Human Skin Blotch
Date of disclosure of the study information 2025/12/01
Last modified on 2025/10/25 17:49:07

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Improvement Effects of Intake of Resveratrol-containing Extracts from the Indian traditional medicine Pterocarpus marsupiumand and Red Wine Combined with Palmitoyl Vitamin C on Human Skin Blotch

Acronym

Effects of Resveratrol Combined with Vitamin C Derivative on Human Skin Blotch

Scientific Title

Improvement Effects of Intake of Resveratrol-containing Extracts from Pterocarpus marsupiumand and Red Wine Combined with Palmitoyl Vitamin C on Human Skin Blotch

Scientific Title:Acronym

Improvement Effects of Resveratrol-containing Extracts from Pterocarpus marsupiumand and Red Wine Combined with Palmitoyl Vitamin C on Human Skin Blotch

Region

Japan


Condition

Condition

Skin Blotch

Classification by specialty

Aesthetic surgery Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

It is clinically examined whether Improvement Effects of Intake of Resveratrol-containing Extracts from Pterocarpus marsupiumand and Red Wine Combined with Palmitoyl Vitamin C on Human Skin Blotch.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2

Pragmatic

Developmental phase

Not applicable


Assessment

Primary outcomes

It is examined whether skin blotch can be improved.

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Cluster

Blinding

Double blind -all involved are blinded

Control

Placebo

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

3

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

Placebo. Intervention by administration for 30 days at a dose of 500-550 mg per one subject, once for a day.

Interventions/Control_2

Vitamin C Palmitate. Intervention by administration for 30 days at a dose of 500-550 mg per one subject, once for a day.

Interventions/Control_3

Resveratrol plus Vitamin C Palmitate. Intervention by administration for 30 days at a dose of 500-550 mg per one subject, once for a day.

Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

27 years-old <=

Age-upper limit

63 years-old >=

Gender

Male and Female

Key inclusion criteria

No diseases, Japanese persons, normal blotch degrees in face and sun-exposed skin.

Key exclusion criteria

Persons with some serious disease. Underage and highly elder.

Target sample size

12


Research contact person

Name of lead principal investigator

1st name Nobuhiko
Middle name
Last name Miwa

Organization

Specified Nonprofit Organization Japanese Center for Anti-Aging Medical Sciences

Division name

Division of Research Development

Zip code

727-0023

Address

Mineta Cho 1177, Shobara City, Hiroshima

TEL

072-320-2900

Email

jpn.cntr.antiaging.medsci2002@leto.eonet.ne.jp


Public contact

Name of contact person

1st name Nobuhiko
Middle name
Last name Miwa

Organization

Specified Nonprofit Organization Japanese Center for Anti-Aging Medical Sciences

Division name

Division of Research Development

Zip code

593-8322

Address

Tsukuno3-29-25, Nishi-ku, Sakai City, Osaka

TEL

070-5679-7416

Homepage URL


Email

vitamin2002rejuvenation@yahoo.co.jp


Sponsor or person

Institute

Specified Nonprofit Organization Japanese Center for Anti-Aging Medical Sciences

Institute

Department

Personal name



Funding Source

Organization

Specified Nonprofit Organization Japanese Center for Anti-Aging Medical Sciences

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Specified Nonprofit Organization Japanese Center for Anti-Aging Medical Sciences

Address

Tsukuno 3-29-25, Nishi-ku, Sakai City, Osaka

Tel

070-5679-7416

Email

vitamin2002rejuvenation@yahoo.co.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2025 Year 12 Month 01 Day


Related information

URL releasing protocol


Publication of results

Partially published


Result

URL related to results and publications


Number of participants that the trial has enrolled

9

Results

Oral administration with 6-O-palmitoyl ascorbate [VcPlm] for C-group, VcPlm plus resveratrol for R-group, or placebo for P-group, for 30 days, respectively. Blotch degrees were not improved for P-group, partially significantly improved for C-group, and appreciably improved for R-group. The blotch degrees were indicated to reflect the densities and areas in photography to each blotch.

Results date posted

2025 Year 10 Month 25 Day

Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

No longer recruiting

Date of protocol fixation

2024 Year 02 Month 01 Day

Date of IRB

2024 Year 06 Month 01 Day

Anticipated trial start date

2024 Year 06 Month 20 Day

Last follow-up date

2025 Year 09 Month 30 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2025 Year 10 Month 25 Day

Last modified on

2025 Year 10 Month 25 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000067917